Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis (Q80242349)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 May 2007
edit
Language Label Description Also known as
English
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
scientific article published on 01 May 2007

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit